<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; The Cooper Companies Incorporated</title>
	<atom:link href="http://www.stockbloghub.com/tag/the-cooper-companies-incorporated/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(COO) Cooper Companies Misses Estimates by 13%</title>
		<link>http://www.stockbloghub.com/2009/09/04/coo-cooper-companies-misses-estimates-by-13/14465</link>
		<comments>http://www.stockbloghub.com/2009/09/04/coo-cooper-companies-misses-estimates-by-13/14465#comments</comments>
		<pubDate>Fri, 04 Sep 2009 23:21:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Instruments & Supplies]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[The Cooper Companies Incorporated]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=14465</guid>
		<description><![CDATA[The Cooper Companies Inc. (COO) reported fiscal third-quarter results yesterday after market close. The company posted GAAP earnings of $21.9 million or 48 cents per share, compared to $17.9 million or 39 cents per share in the year-ago period. Excluding restructuring charges, pro forma earnings per share came in at 54 cents, which missed the Zacks Consensus Estimate by nearly 13%, or 8 cents. Cooper manufactures and markets specialty healthcare products through its CooperVision and CooperSurgical units. CooperVision makes contact lenses to correct visual defects. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women&#8217;s healthcare market. The company has manufacturing facilities in the U.S., U.K., Australia and Spain. The Pleasanton, CA-based company posted a 2% year-over-year growth in sales to $285.2 million. CooperVision unit’s revenue grew 2% year ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/09/04/coo-cooper-companies-misses-estimates-by-13/14465/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COO) The Cooper Companies, Inc &#8211; Value &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/04/20/coo-the-cooper-companies-inc-value-zacks-rank-buy/5757</link>
		<comments>http://www.stockbloghub.com/2009/04/20/coo-the-cooper-companies-inc-value-zacks-rank-buy/5757#comments</comments>
		<pubDate>Mon, 20 Apr 2009 20:09:09 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Instruments & Supplies]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[The Cooper Companies Incorporated]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=5757</guid>
		<description><![CDATA[Cooper Companies, Inc. (COO) analysts are raising estimates and shares are rising consistently. Company Description The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women&#8217;s healthcare market. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical lenses and lenses for patients with more complex vision disorders. Growth and Value Cooper analysts&#8217; estimates are averaging $2.30 for full year 2009, up from $2.15 60 days ago. Forecasts for next year are averaging $2.57, up from $2.45 over the same time span. These forecasts are calling for just 1.6% growth this year, but 12% in 2010. Rates are relatively cheap, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/20/coo-the-cooper-companies-inc-value-zacks-rank-buy/5757/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COO) The Cooper Companies, Inc. &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/04/02/coo-the-cooper-companies-inc-momentum-zacks-rank-buy/5016</link>
		<comments>http://www.stockbloghub.com/2009/04/02/coo-the-cooper-companies-inc-momentum-zacks-rank-buy/5016#comments</comments>
		<pubDate>Thu, 02 Apr 2009 19:26:01 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Instruments & Supplies]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[The Cooper Companies Incorporated]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=5016</guid>
		<description><![CDATA[The Cooper Companies, Inc. (COO) continues to perform well in a touch market, with the company&#8217;s recent first-quarter results coming in ahead of expectations. Company Description The Cooper Companies, Inc., through its subsidiaries, develops and manufactures healthcare products both domestically and internationally. The company was founded in 1980 and has a market cap of $1.19 billion. Industry Strength Cooper Cos. operates in the medical products industry, a segment of the market that has held up relatively well during the market declines of the last 12 months. This held true when the company reported strong first-quarter results on Mar 5. First-Quarter Results Sales were up 3% to $251.1 million. Income came in at $23.9 million, a huge jump from $6.9 million last year. This produced earnings of 57 cents per share, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/02/coo-the-cooper-companies-inc-momentum-zacks-rank-buy/5016/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COO) Cooper Companies, Inc &#8211; Aggressive Growth &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/03/12/coo-cooper-companies-inc-aggressive-growth-zacks-rank-buy/4264</link>
		<comments>http://www.stockbloghub.com/2009/03/12/coo-cooper-companies-inc-aggressive-growth-zacks-rank-buy/4264#comments</comments>
		<pubDate>Thu, 12 Mar 2009 22:50:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Instruments & Supplies]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[The Cooper Companies Incorporated]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=4264</guid>
		<description><![CDATA[Cooper Companies, Inc. (COO) just reported solid revenue and earnings growth. Margins are improving and shares are on the rise. Company Description The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women&#8217;s healthcare market. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical lenses and lenses for patients with more complex vision disorders. Third Consecutive Surprise On Mar 5 Cooper announce first-quarter results for fiscal 2009 that included earnings per share of 57 cents per share, 43% above the consensus of 40 cents. Earnings rose 50% from last year&#8217;s mark of 38 cents. Earnings were driven by a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/03/12/coo-cooper-companies-inc-aggressive-growth-zacks-rank-buy/4264/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COO) The Cooper Companies &#8211; actively cutting costs and focusing on gaining market share</title>
		<link>http://www.stockbloghub.com/2009/02/18/the-cooper-companies-actively-cutting-costs-and-focusing-on-gaining-market-share/2755</link>
		<comments>http://www.stockbloghub.com/2009/02/18/the-cooper-companies-actively-cutting-costs-and-focusing-on-gaining-market-share/2755#comments</comments>
		<pubDate>Wed, 18 Feb 2009 16:08:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Instruments & Supplies]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[The Cooper Companies Incorporated]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=2755</guid>
		<description><![CDATA[The Cooper Companies, Inc. (COO), which manufactures contact lenses, beat fourth quarter estimates by 12.07% as it recorded record revenue in fiscal 2008. The company has surprised on estimates 3 out of the last 4 quarters by an average of 4.38%. COO is trading at 9.3x forward earnings. Company Description The Cooper Companies manufactures specialty healthcare products. The company has two divisions: CooperVision and CooperSurgical. CooperVision manufactures soft contact lenses and specializes in lenses for astigmatism, presbyopia and ocular dryness. The company produces monthly, 2-week and daily disposable contact lenses. CooperSurgical manufactures medical devices, diagnostic products and surgical instruments mainly used by gynecologists and obstetricians. Record Revenue in Fiscal 2008 On Dec 9, The Cooper Companies reported fourth-quarter 2008 earnings which beat Wall Street estimates by 12.07%. Earnings per share ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/02/18/the-cooper-companies-actively-cutting-costs-and-focusing-on-gaining-market-share/2755/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

